These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36949303)

  • 61. Dysfunction of Microglial STAT3 Alleviates Depressive Behavior via Neuron-Microglia Interactions.
    Kwon SH; Han JK; Choi M; Kwon YJ; Kim SJ; Yi EH; Shin JC; Cho IH; Kim BH; Jeong Kim S; Ye SK
    Neuropsychopharmacology; 2017 Sep; 42(10):2072-2086. PubMed ID: 28480882
    [TBL] [Abstract][Full Text] [Related]  

  • 62. How Stress Shapes Neuroimmune Function: Implications for the Neurobiology of Psychiatric Disorders.
    Koo JW; Wohleb ES
    Biol Psychiatry; 2021 Jul; 90(2):74-84. PubMed ID: 33485589
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genomic perspectives on the circadian clock hypothesis of psychiatric disorders.
    von Schantz M; Leocadio-Miguel MA; McCarthy MJ; Papiol S; Landgraf D
    Adv Genet; 2021; 107():153-191. PubMed ID: 33641746
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Microglia-Neuron Communication in Epilepsy.
    Eyo UB; Murugan M; Wu LJ
    Glia; 2017 Jan; 65(1):5-18. PubMed ID: 27189853
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.
    Wesseling H; Gottschalk MG; Bahn S
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539505
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PU.1 regulates Alzheimer's disease-associated genes in primary human microglia.
    Rustenhoven J; Smith AM; Smyth LC; Jansson D; Scotter EL; Swanson MEV; Aalderink M; Coppieters N; Narayan P; Handley R; Overall C; Park TIH; Schweder P; Heppner P; Curtis MA; Faull RLM; Dragunow M
    Mol Neurodegener; 2018 Aug; 13(1):44. PubMed ID: 30124174
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view.
    Stolero N; Frenkel D
    J Neurochem; 2021 Sep; 158(6):1412-1424. PubMed ID: 33314073
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy: Implications for psychiatric disorders.
    Xu H; Zhang H; Zhang J; Huang Q; Shen Z; Wu R
    Neurosci Biobehav Rev; 2016 Dec; 71():563-577. PubMed ID: 27702600
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of expression quantitative trait loci associated with schizophrenia and affective disorders in normal brain tissue.
    Bhalala OG; Nath AP; ; Inouye M; Sibley CR
    PLoS Genet; 2018 Aug; 14(8):e1007607. PubMed ID: 30142156
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mitochondrial dysfunction and psychiatric disorders.
    Rezin GT; Amboni G; Zugno AI; Quevedo J; Streck EL
    Neurochem Res; 2009 Jun; 34(6):1021-9. PubMed ID: 18979198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
    Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
    Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies.
    Stuart MJ; Baune BT
    Neurosci Biobehav Rev; 2014 May; 42():93-115. PubMed ID: 24513303
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression.
    Wang H; He Y; Sun Z; Ren S; Liu M; Wang G; Yang J
    J Neuroinflammation; 2022 Jun; 19(1):132. PubMed ID: 35668399
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study.
    Szpak GM; Lechowicz W; Lewandowska E; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Schmidt-Sidor B; Dymecki J
    Folia Neuropathol; 2001; 39(3):181-92. PubMed ID: 11770129
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Shedding Light on the Dark Side of the Microglia.
    St-Pierre MK; Šimončičová E; Bögi E; Tremblay MÈ
    ASN Neuro; 2020; 12():1759091420925335. PubMed ID: 32443939
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Shaping Neuronal Fate: Functional Heterogeneity of Direct Microglia-Neuron Interactions.
    Cserép C; Pósfai B; Dénes Á
    Neuron; 2021 Jan; 109(2):222-240. PubMed ID: 33271068
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microglia-Specific Metabolic Changes in Neurodegeneration.
    Aldana BI
    J Mol Biol; 2019 Apr; 431(9):1830-1842. PubMed ID: 30878483
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.
    Cassano GB; Pini S; Saettoni M; Rucci P; Dell'Osso L
    J Clin Psychiatry; 1998 Feb; 59(2):60-8. PubMed ID: 9501887
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anxiety symptoms in a major mood and schizophrenia spectrum disorders.
    Karpov B; Joffe G; Aaltonen K; Suvisaari J; Baryshnikov I; Näätänen P; Koivisto M; Melartin T; Oksanen J; Suominen K; Heikkinen M; Paunio T; Isometsä E
    Eur Psychiatry; 2016 Sep; 37():1-7. PubMed ID: 27447101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.